Holen Sie sich die Stockscreener-App
0.9598
1.04%
-0.0101
Finanzdaten der Unity Biotechnology Inc-Aktie (UBX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
1.02%
7.599
|
7.677 | 14.58 | 11.85 | 10.56 |
| Interest Income/Expense |
100.00%
-
|
0.001 | 0.566 | 0.883 | 1.002 |
| Operating Income/Loss |
1.02%
-7.599
|
-7.677 | -14.58 | -11.85 | -10.56 |
| Income/Loss From Continuing Operations Before Tax |
33.41%
-5.79
|
-4.34 | -14.78 | -15.46 | -5.279 |
| Income/Loss From Continuing Operations After Tax |
33.41%
-5.79
|
-4.34 | -14.78 | -15.46 | -5.279 |
|
Net Income/Loss
|
33.41%
-5.79
|
-4.34 | -14.78 | -15.46 | -5.279 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,034%
16.79
|
0.3269 | 14.60 | 14.43 | 14.31 |
| Diluted Average Shares |
5,034%
16.79
|
0.3269 | 14.60 | 14.43 | 14.31 |
| Basic Earnings Per Share |
41.67%
-0.34
|
-0.24 | -1.01 | -1.07 | -0.37 |
| Diluted Earnings Per Share |
41.67%
-0.34
|
-0.24 | -1.01 | -1.07 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):